Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-25-002103
Filing Date
2025-02-11
Accepted
2025-02-11 16:31:12
Documents
1
Period of Report
2025-02-07

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 4925
  Complete submission text file 0001062993-25-002103.txt   6519
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Issuer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address C/O CRISPR THERAPEUTICS 610 MAIN STREET CAMBRIDGE MA 02139
Business Address
Morrow Phuong Khanh (Reporting) CIK: 0001928989 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36569 | Film No.: 25610299